Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Apotheca Biosciences Inc CBDC

Consumer Defensive Healthcare Packaged Foods Biotechnology
Apotheca Biosciences Inc is engaged in is developing medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry. The company's products in the pipeline include transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids.

Recent & Breaking News (OTCPK:CBDC)

Apotheca Biosciences (PCFP) to Change Ticker Symbol to CBDC Effective at the Open of Business April 4, 2019

GlobeNewswire April 3, 2019

Apotheca Biosciences (PCFP) Begins Shipping ProMED CBD, Our Newest Flag-Ship Pharma Grade CBD Product Line by ProMED Biosciences - Company Begins with 11 Product SKUs increasing to 30 Product SKUs by Second Quarter

GlobeNewswire April 1, 2019

Apotheca Biosciences (PCFP) Appoints Veteran Senior Executive from Multinational Pharmaceutical Company as President & CEO

GlobeNewswire February 6, 2019

Apotheca Biosciences (PCFP) Introduces ProMED, Our Newest Flagship Product Line -- Company Begins Rolling Out its Sleep Aid & Opioid Replacement Formulations

GlobeNewswire January 15, 2019

Apotheca Biosciences (PCFP) Announces the Roll Out of Apotheca Earth, Direct to Business & Consumer Medical Grade CBD Products - Apotheca Earth to Begin National Sales & Marketing Campaign

GlobeNewswire December 10, 2018

Apotheca Biosciences (PCFP) Plans Uplisting to OTCQB

GlobeNewswire November 12, 2018

Various Technological Advancements are set to Grow the Global Biotechnology Market

PR Newswire November 9, 2018

Apotheca Biosciences (PCFP) Signs an LOI For Purchase of Nano Creaciones S.A. P.I. de C.V - Nano Develops Gauze, Band-Aids & Sprays Using CBD as Palliative

GlobeNewswire November 6, 2018

Apotheca Biosciences (PCFP) Announces Addition of Dr. Herbert Weissbach to the Cannabis Scientific Advisory Board - Dr. Weissbach’s Primary Research Interest in Aging and Age-Related Diseases

GlobeNewswire November 1, 2018

Apotheca Biosciences (PCFP) Announces Addition of Dr. Mali Reddy, Seven Time Nobel Prize Nominee, as Chief Medical Adviser & Medical Researcher

GlobeNewswire October 15, 2018

Apotheca Biosciences (PCFP) & CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High

GlobeNewswire October 8, 2018

Apotheca Biosciences (PCFP) Overviews GameDayRx, CBD & Cannabis Tailor-Made for Athletes

GlobeNewswire September 27, 2018

Apotheca Biosciences (PCFP) Overviews Pain-Patch, an Opioid Substitution

GlobeNewswire September 17, 2018

Cannabis Leaf is Now Apotheca Biosciences (PCFP), Company's Products and R & D Focuses on Opioid Crisis, a National Public Health Emergency

GlobeNewswire September 4, 2018

Cannabis Leaf (PCFP) Completes Merger with Apotheca Biosciences – Company’s R & D Focuses on Opioid Crisis, a National Public Health Emergency

GlobeNewswire June 25, 2018

Cannabis Leaf (PCFP) Apotheca Biosciences is Launching RAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing - Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption

GlobeNewswire June 5, 2018

Cannabis Leaf (PCFP) Apotheca Biosciences Provides Corporate Update Solving Opioid Addiction is Our First Priority

GlobeNewswire May 23, 2018

Cannabis Leaf (PCFP) Apotheca Biosciences Secures the Intellectual Patent Rights for Pain-Patch (TM), a Cannabinoid Pain Alleviation Technology

GlobeNewswire May 8, 2018

Apotheca Biosciences (PCFP) R & D Focuses on Opioid Crisis, a National Public Health Emergency

GlobeNewswire April 17, 2018

Cannabis Leaf (PCFP) Merges with Apotheca Biosciences to Create Cutting-Edge Medical Products & Cannabinoids Delivery Technologies

GlobeNewswire March 29, 2018